KLOX-SAB Study
Cross-source consensus on KLOX-SAB Study from 1 sources and 4 claims.
1 sources · 4 claims
Other
Other
Other
Other
Highlighted claims
- KLOX-SAB is a multicentre prospective observational clinical trial in southeast Sweden. — Unbound cloxacillin plasma concentrations in relation to toxicity and renal function: protocol for a prospective, observational clinical trial in a real-world Staphylococcus aureus bacteraemia population
- The study targets 95 adult patients with methicillin-susceptible Staphylococcus aureus bacteraemia treated with cloxacillin. — Unbound cloxacillin plasma concentrations in relation to toxicity and renal function: protocol for a prospective, observational clinical trial in a real-world Staphylococcus aureus bacteraemia population
- Trial participation lasts 30 days, with intensive in-hospital sampling and assessment during the first 7 days. — Unbound cloxacillin plasma concentrations in relation to toxicity and renal function: protocol for a prospective, observational clinical trial in a real-world Staphylococcus aureus bacteraemia population
- The study is registered as a low-interventional clinical trial and follows Good Clinical Practice standards. — Unbound cloxacillin plasma concentrations in relation to toxicity and renal function: protocol for a prospective, observational clinical trial in a real-world Staphylococcus aureus bacteraemia population